Jove
Visualize
Contact Us

Related Experiment Videos

Center variability.

M R Mickey

    Clinical Transplants
    |January 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Kidney transplant outcomes vary significantly between medical centers, influenced by practices like cyclosporine (CsA) use and cold ischemia times. Some centers achieve over 90% graft survival, highlighting the impact of center-specific protocols on patient success.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    SEROTYPING FOR HOMOTRANSPLANTATION. VII. SELECTION OF KIDNEY DONORS FOR THIRTY-TWO RECIPIENTS.

    Annals of the New York Academy of Sciences·2010
    Same author

    Design strategies in multiple sclerosis clinical trials. The Cyclosporine Multiple Sclerosis Study Group.

    Annals of neurology·1994
    Same author

    Survival of children with chronic myeloid leukemia.

    The American journal of pediatric hematology/oncology·1992
    Same author

    National allocation of cadaveric kidneys by HLA matching. Projected effect on outcome and costs.

    The New England journal of medicine·1991
    Same author

    Molecular HLA matching.

    Transplantation proceedings·1991
    Same author

    A report from the UNOS Scientific Renal Transplant Registry.

    Transplantation proceedings·1991
    Same journal

    Clinical Relevance of Donor-Specific IgM Antibodies in HLA Incompatible Renal Transplantation: A Retrospective Single-Center Study.

    Clinical transplants·2017
    Same journal

    Influenza Immunization and the Generation of Anti-HLA and Anti-MICA Antibodies in Patients with Renal Failure and in Kidney Transplant Recipients.

    Clinical transplants·2017
    Same journal

    From Accurate Assessment of Anti-HLA Antibody MFI to Complement-Binding Assays.

    Clinical transplants·2017
    Same journal

    Post-transplant Desensitization for Deceased Donor Kidney Transplant Recipients: A Single Center Experience.

    Clinical transplants·2017
    Same journal

    Acute Rejection in 6-Antigen HLA-Matched Kidney Transplant Recipients: Risk Factors and Outcomes from the Wisconsin Allograft Recipient Database (WisARD).

    Clinical transplants·2017
    Same journal

    C1q Donor-Specific Antibody Associates with Post-transplant Biopsy Findings in Highly- Sensitized Kidney Transplant Recipients.

    Clinical transplants·2017
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies

    Area of Science:

    • Nephrology
    • Transplantation Surgery
    • Immunosuppression Therapy

    Background:

    • Kidney transplant graft survival rates exhibit considerable variation across different medical centers.
    • Understanding the factors contributing to this variation is crucial for improving patient outcomes.
    • Cyclosporine (CsA) and pretransplant transfusions are key management elements in kidney transplantation.

    Purpose of the Study:

    • To investigate the extent and sources of variation in kidney transplant graft survival among different centers.
    • To identify specific center-based practices associated with graft survival outcomes.
    • To explore the relationship between immunosuppressive drug use, pretransplant interventions, and transplant outcomes.

    Main Methods:

    • Analysis of kidney transplant data from multiple centers.

    Related Experiment Videos

  • Statistical assessment of assignable variation in graft survival.
  • Correlation analysis of center-specific practices (CsA use, cold ischemia time, transfusions) with graft survival rates.

    • Main Results:

    • Center variation accounted for approximately one-third of the assignable variation in kidney transplant graft survival.
    • Systematic differences in CsA use, pretransplant transfusions, and cold ischemia times were observed across centers.
    • Some centers achieved excellent graft survival rates (over 90%) for first cadaveric donor transplants.
    • A negative correlation was noted between higher graft survival rates and reduced use of CsA.

    Conclusions:

    • Center-specific practices significantly impact kidney transplant graft survival.
    • Optimizing protocols related to immunosuppression and transplant management can lead to improved outcomes.
    • Further research into the nuances of center variation may reveal strategies for enhancing kidney transplant success nationwide.